Global Transcatheter Embolization and Occlusion Market, By Type (Coil, Non Coil), Application (Peripheral Vascular Disease, Oncology, Neurology, Urology), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Transcatheter Embolization and Occlusion Market
The transcatheter embolization and occlusion marketis expected to witness market growth at a rate of 8.85% in the forecast period of 2021 to 2028. Data Bridge Market Research report on transcatheter embolization and occlusion market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.The rise in the healthcare sector globally is escalating the growth of transcatheter embolization and occlusion market.
Transcatheter embolization and occlusion (TEO) refers to a minimally invasive (MI) procedure that is performed in interventional radiology wherein a synthetic embolus isinserted or placed through a fine catheter. Coilsare permanent embolic agents that are available in various shapes and sizes and coated with chemotherapeutic drugs blocking blood supply and induce cytotoxicity to attack the tumour.
The rise in prevalence of chronic diseasesamong population across the globe acts as one of the major factors driving the growth of transcatheter embolization and occlusion market.The high use of these devices helps avoid complications, such as imprecise deployment, catheter entrapment, and balloon deflation associated with coiling, and increase in shift toward non coil devices to leverage on the benefitsfurther influence the market. Initiatives by various governments in the region to improve healthcare infrastructure and manufacturing industry and rise in risk factors such as unhealthy dietary habits, tobacco and alcohol consumption, and obesity further influence the market. Additionally, advantages associated with minimally invasive treatment, surge in healthcare expenditure, and rise in geriatric population positively affects the transcatheter embolization and occlusion market. Furthermore, advancements in healthcare sector and growing medical tourismextend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand,high cost of products is expected to obstruct the market growth. The presence of stringent regulatory framework for product commercialization is projected to challenge the transcatheter embolization and occlusion marketin the forecast period of 2021-2028.
This transcatheter embolization and occlusion market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on transcatheter embolization and occlusion market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Transcatheter Embolization and Occlusion Market Scope and Market Size
The transcatheter embolization and occlusion market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the transcatheter embolization and occlusion market is segmented into coil, and non-coil. Coil is further segmented into pushable coils and detachable coils. Non coil is further segmented into flow diverting devices, embolization particles, liquid embolics and other embolization and occlusion devices and accessories.
- On the basis of application, the transcatheter embolization and occlusion market is segmented into peripheral vascular disease, oncology, neurology and urology. Peripheral vascular disease is further segmented into arterial blockage, venous blood clot and others. Oncology is further segmented into liver cancer, pancreatic cancer, breast cancer, kidney cancer and others. Neurology is further segmented into brain aneurysm, cerebral arteriovenous malformations and others. Urology is further segmented into benign prostatic hyperplasia/urinary retention and others.
Transcatheter Embolization and Occlusion Market Country Level Analysis
The transcatheter embolization and occlusion market is analyzed and market size insights and trends are provided by country, type and application as referenced above.
The countries covered in the transcatheter embolization and occlusion market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the transcatheter embolization and occlusion market because of the presence of advanced healthcare infrastructure, and well-defined regulatory framework within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to therapidly growing medical tourism industry in emerging economies, such as India, China, and Malaysia.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The transcatheter embolization and occlusion market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transcatheter embolization and occlusion market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transcatheter embolization and occlusion market. The data is available for historic period 2010-2019.
Competitive Landscape and Scalpels Market Share Analysis
The transcatheter embolization and occlusion market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to transcatheter embolization and occlusion market.
The major players covered in the transcatheter embolization and occlusion market report areBTG International Ltd., Boston Scientific Corporation, Medtronic, Penumbra, Inc, Cook, Edwards Lifesciences Corporation, Merit Medical Systems, Johnson & Johnson Services, Inc, Pfizer Inc., Stryker, Terumo Corporation, Sirtex Medical, and Abbott, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-